Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-29

Clinical Trial Update: Assessment of Artesunate/Mefloquine in the Peruvian Amazon [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating artesunate/mefloquine use in falciparum malaria in the Peruvian Amazon completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate-mefloquine (artesunate-mefloquine)

Snippet

Sponsor: Instituto Nacional de Salud. Peru | Conditions: Malaria, Falciparum | Phase 4 | Status: COMPLETED